St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Learn about published research as well as leading-edge basic and translational research initiatives from St. Jude laboratories.
Kristin Lyons, director of Rehabilitation Services, and Jessica Sparrow, Lead Occupational Therapist, worked as part of a team of oncology rehabilitation providers from pediatric institutions across the country to co-author a recent Seminars in Oncology Nursing article, which provides a comprehensive overview of rehabilitation screening, assessment, and intervention for children with cancer.
Posterior fossa syndrome develops in some children following surgery for the brain tumor medulloblastoma. St. Jude research offers fresh insight into the mysterious syndrome and advice on how to avoid it.
As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.
Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.
Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.
Genetic changes in the biology of blood cells can lead them down a path to cancer. This researcher is figuring out how that happens.
Leader, mentor, scientist, physician and gene therapy pioneer: Arthur Nienhuis' extensive legacy of science and medicine.
This viral infection is so common nearly everyone has had it - and it can become deadly serious for those who have compromised immune systems.
St. Jude highlights Regina Kolaitis, PhD, who shares the moment she learned about the connection between her research and the people it helped.
This new computational tool pinpoints errors in ultra deep sequencing to identify residual cancer cells that normal sequencing misses.